Literature DB >> 7964696

The auditory startle response in progressive supranuclear palsy.

J C Rothwell1, M Vidailhet, P D Thompson, A J Lees, C D Marsden.   

Abstract

The EMG characteristics of the normal auditory startle response in man are compatible with an origin in the pontine reticular formation and with conduction down the spinal cord in a slowly conducting, possibly reticulo-spinal pathway. The startle was reduced or absent in patients with progressive supranuclear palsy, consistent with loss of neurones in the lower pontine reticular formation. In contrast, the startle was present and of normal form in patients with Parkinson's disease. However, it was delayed in onset. This result was not influenced by treatment with L-dopa. The late auditory startle in Parkinson's disease might be related to withdrawal of facilitatory input to brainstem centres from the basal ganglia.

Entities:  

Mesh:

Year:  1994        PMID: 7964696     DOI: 10.1007/978-3-7091-6641-3_4

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  4 in total

1.  Startle responses in Parkinson patients during human gait.

Authors:  P H J A Nieuwenhuijzen; M W Horstink; B R Bloem; J Duysens
Journal:  Exp Brain Res       Date:  2005-11-24       Impact factor: 1.972

2.  Sleep bruxism is related to decreased inhibitory control of trigeminal motoneurons, but not with reticulobulbar system.

Authors:  Rahşan İnan; Gülçin Benbir Şenel; Figen Yavlal; Derya Karadeniz; Ayşegül Gündüz; Meral E Kızıltan
Journal:  Neurol Sci       Date:  2016-09-14       Impact factor: 3.307

3.  Auditory startle response is normal in juvenile myoclonic epilepsy.

Authors:  Melek Kandemir; Ayşegül Gündüz; Nurten Uzun; Naz Yeni; Meral Kızıltan
Journal:  Neurol Sci       Date:  2015-03-25       Impact factor: 3.307

4.  Human wildtype tau expression in cholinergic pedunculopontine tegmental neurons is sufficient to produce PSP-like behavioural deficits and neuropathology.

Authors:  Gabriella King; Kaliana M Veros; Duncan Archibald Allan MacLaren; Martin Peter Konrad Leigh; Joseph A Spernyak; Stewart D Clark
Journal:  Eur J Neurosci       Date:  2021-11-02       Impact factor: 3.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.